Gilbert “Lynn” Marks, M.D., is a senior advisor at Tunnell Government Services, Inc., where he supports the Office of the Director, Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. Prior to joining Tunnell, Marks retired from GlaxoSmithKline (GSK) pharmaceuticals, where he served as senior vice president of research and development (R&D). During his 25-year tenure at GSK, he took on increasing levels of global accountability, including serving as head of the Infectious Diseases Therapy Area and later overseeing a large global organization that delivered, analyzed and reported clinical trials, Phase I-IV, covering all therapeutic areas for Pharma and across more than 55 countries. In addition, Marks managed the clinical development teams in Japan and China. Furthermore, he helped stand up the cross-Pharma organization, Transcelerate BioPharma, focusing on quality, safety and efficiency for R&D organizations. Marks is a member of the board of directors for WOAR Women Organized Against Rape, Philadelphia’s nonprofit, social services organization, supporting victims of sexual violence and rape. He is board certified in internal medicine and infectious diseases.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- NCATS Chemical Genomics Center (NCGC)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Trans-NIH RNAi Facility (TNRF)
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- About NCATS
- Advisory Groups
- NCATS Advisory Council
- Council Roster
- Gilbert “Lynn” Marks, M.D. (2020)
Gilbert “Lynn” Marks, M.D. (2020)
- Funding & Notices
-